Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00488865 · ClinicalTrials.gov registry record · NA
RexMedical- Option* Vena Cava Filter IDE Study
A NA study, sponsored by Rex Medical.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT00488865: Completed NA study, sponsored by Rex Medical.
NCT00488865 is a NA study that has completed, run by Rex Medical. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00488865, a NA study, has completed, sponsored by Rex Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study is designed to evaluate the safety and efficacy of the RexMedical Option\* Vena Cava Filter in the treatment of patients who are at increased risk for Pulmonary Embolism and require caval interruption.
Primary Outcome
Placement Technical Success without subsequent pulmonary embolism, significant filter migration, symptomatic caval thrombosis or other complication requiring filter removal or invasive intervention to address condition.
Interventions
- DEVICE Intravascular Filter Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2006-10 |
| Est. Completion | 2009-06 |
| Phase | NA |
What the finished NCT00488865 record still lists
NCT00488865 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Intravascular Filter Device is the first listed.
NCT00488865 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00488865 about?
NCT00488865 is a clinical study titled "RexMedical- Option* Vena Cava Filter IDE Study". This study is designed to evaluate the safety and efficacy of the RexMedical Option\* Vena Cava Filter in the treatment of patients who are at increased risk for Pulmonary Embolism and require caval interruption.
What is the current status of trial NCT00488865?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2006-10. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00488865?
The interventions under investigation include: Intravascular Filter Device (DEVICE).
Who is sponsoring clinical trial NCT00488865?
This trial is sponsored by Rex Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00488865's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia